Physical inactivity associated with the burden of global non-communicable diseases and deaths

The health implications of physical inactivity are truly a global issue with physical inactivity responsible for up to 8% of non-communicable diseases and deaths across the world, finds research published online in British Journal of Sports Medicine.

It is in high-income countries that physical inactivity has the greater relative impact on non-communicable disease and death (in terms of increased risk to the average person), but it is middle-income countries that have the greatest number of people affected by physical inactivity and face the biggest strain on health resources.

Physical inactivity is a known risk factor for premature mortality and several non-communicable diseases, including coronary heart disease, stroke, hypertension, type 2 diabetes, and several cancers.

Levels of physical inactivity increase according to the income levels of countries, and in 2016 levels of physical inactivity in high-income countries were estimated to be more than double those in low-income countries.

With physical inactivity increasing across the globe and 80% of non-communicable disease deaths now occurring in low- and middle-income countries, the authors set out to estimate the current burden of global non-communicable disease associated with physical inactivity.

From the scientific literature they obtained estimates of the impact physical inactivity has on major health outcomes (relative risks) and data on physical inactivity levels for 168 countries in 2016.

These data were used to estimate how much disease could be averted in each of the 168 countries through increased physical activity by calculating population-level, prevalence-based population attributable risks (PAR) for each outcome in each country and then collating the results.

Physical inactivity was defined as less than 150 minutes of moderate-intensity or 75 minutes of vigorous-intensity physical activity per week.

The calculations show that the proportions of non-communicable diseases attributable to physical inactivity ranges from 1.6% for hypertension to 8.1% for dementia. Population-level, prevalence-based population attributable risks increase with countries’ income levels and are more than two times higher in high-income countries than they are in low-income ones.

While the burden per average individual is greater in high-income countries, it is middle income countries that are hit harder overall because of their greater population sizes, the results show. This means 69% of all deaths and 74% of cardiovascular disease deaths associated with physical inactivity occur in middle-income countries.

In general, the highest burden of non-communicable disease associated with physical inactivity is in Latin American and Caribbean countries, and high-income Western and Asia Pacific countries. The lowest burden is in countries in sub-Saharan Africa, Oceania and East and Southeast Asia.

This is an observational study, and as such, can’t establish cause, and the authors point to some limitations. For example, the population-based approach used to estimate the disease burden results was theoretical, competing risks were not accounted for, and the relative risks used to determine the impact of physical inactivity on health outcomes were not country specific.

In 2018, the World Health Assembly adopted a target to reduce global levels of physical inactivity by 15% by 2030.

“The global health burden associated with physical inactivity is substantial,” the authors conclude. “The public health burden associated with physical inactivity is truly a global issue that will require international collaboration to mobilize change and achieve these public health goals.”

Source:
Journal reference:

Katzmarzyk, P.T., et al. (2021) Physical inactivity and non-communicable disease burden in low-income, middle-income and high income countries. British Journal of Sports Medicine. doi.org/10.1136/bjsports-2020-103640.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Tirzepatide improves heart health and function in obese HFpEF patients